106 results
The main aim of the current study is to investigate whether two promising therapies, namely cognitive rehabilitation therapy (CRT) and mindfulness based cognitive therapy (MBCT), may improve cognitive functioning of patients with MS. Additionally,…
Improves the alpha blocker Silodosin the bladder emptying in patients with MS? Improves the alpha blocker Silodosin the quality of life of patients with MS?
The aim of the proposed study is to obtain insight into the temporal dynamics of functional reorganization and cognition, and to assess the effect of cognitive rehabilitation on this adaptive mechanism and cognitive functioning.
The aim of this pilot study is to investigate the feasibility and to gain preliminary information on the effectiveness of a cognitive rehabilitation program in patients with (severe) progressive MS, i.e. a speed of processing training (SPT).…
This study will evaluate the efficacy and safety of ocrelizumab in patients with relapsing remitting multiple sclerosis (RRMS) who have a suboptimal response to an adequate course of a disease modifying treatment (DMT).
To assess PK of MPhs and MP.